Premium
HIF ‐1α triggers long‐lasting glutamate excitotoxicity via system x c − in cerebral ischaemia–reperfusion
Author(s) -
Hsieh ChiaHung,
Lin YuJung,
Chen WeiLing,
Huang YenChih,
Chang ChiWei,
Cheng FuChou,
Liu RenShyan,
Shyu WoeiCherng
Publication year - 2017
Publication title -
the journal of pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.964
H-Index - 184
eISSN - 1096-9896
pISSN - 0022-3417
DOI - 10.1002/path.4838
Subject(s) - excitotoxicity , glutamate receptor , glutamatergic , nmda receptor , pharmacology , biology , ischemia , neuroscience , microbiology and biotechnology , chemistry , receptor , medicine , biochemistry
Abstract Hypoxia‐inducible factor 1α ( HIF ‐1α) controls many genes involved in physiological and pathological processes. However, its roles in glutamatergic transmission and excitotoxicity are unclear. Here, we proposed that HIF ‐1α might contribute to glutamate‐mediated excitotoxicity during cerebral ischaemia–reperfusion ( CIR ) and investigated its molecular mechanism. We showed that an HIF ‐1α conditional knockout mouse displayed an inhibition in CIR ‐induced elevation of extracellular glutamate and N ‐methyl‐ d ‐aspartate receptor ( NMDAR ) activation. By gene screening for glutamate transporters in cortical cells, we found that HIF ‐1α mainly regulates the cystine–glutamate transporter (system x c − ) subunit xCT by directly binding to its promoter; xCT and its function are up‐regulated in the ischaemic brains of rodents and humans, and the effects lasted for several days. Genetic deletion of xCT in cortical cells of mice inhibits either oxygen glucose deprivation/reoxygenation ( OGDR ) or CIR ‐mediated glutamate excitotoxicity in vitro and in vivo . Pharmaceutical inhibition of system x c − by a clinically approved anti‐cancer drug, sorafenib, improves infarct volume and functional outcome in rodents with CIR and its therapeutic window is at least 3 days. Taken together, these findings reveal that HIF ‐1α plays a role in CIR ‐induced glutamate excitotoxicity via the long‐lasting activation of system x c − ‐dependent glutamate outflow and suggest that system x c − is a promising therapeutic target with an extended therapeutic window in stroke. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.